Healthequity is a leading provider of health savings accounts and other consumer-directed benefits, facilitating individuals and employers in managing healthcare expenses
The company offers a robust platform that integrates various services, including healthcare spending accounts, wellness services, and insurance products, aimed at empowering consumers to make informed healthcare decisions. By promoting cost-saving strategies and enhancing access to critical healthcare resources, Healthequity plays a vital role in the healthcare ecosystem, making it easier for users to navigate their financial responsibilities associated with medical care.
HealthEquity's Q4 revenue beat estimates, but EPS missed. Raymond James upgraded the stock to Strong Buy, citing long-term growth despite fraud concerns.
Avalo Therapeutics' AVTX-009 is advancing in hidradenitis suppurativa, with Phase 2 data expected in 2026. Stifel initiates coverage with a $36 price target.
CFO James Lucania said on the earnings call that fraud prevention efforts are ongoing, and service expenses are expected to remain elevated through the first half of fiscal 2026.
Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session.
